Truist Bumps Up Exponent's Price Target By 4%

  • Exponent Inc's EXPO price target has been raised to $120 (an upside of 12%) from $115 by Truist analyst Tobey Sommer after hosting the company's CEO and CFO for investor meetings.
  • The analyst maintained a Buy rating on the shares.
  • Sommer noted that the company's domestic court activity has continued to improve through the first quarter. He views Exponent's initial 2022 margin guidance as a "conservative benchmark."
  • The analyst expects the company to benefit from increased investment in infrastructure and energy transition measures.
  • Price Action: EXPO shares are trading higher by 1.99% at $107.68 on the last check Tuesday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!